17-49405058-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The ENST00000300408.8(PHB1):c.753C>T(p.Leu251Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00092 in 1,594,862 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0048 ( 4 hom., cov: 33)
Exomes 𝑓: 0.00051 ( 9 hom. )
Consequence
PHB1
ENST00000300408.8 synonymous
ENST00000300408.8 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.704
Genes affected
PHB1 (HGNC:8912): (prohibitin 1) This gene is evolutionarily conserved, and its product is proposed to play a role in human cellular senescence and tumor suppression. Antiproliferative activity is reported to be localized to the 3' UTR, which is proposed to function as a trans-acting regulatory RNA. Several pseudogenes of this gene have been identified. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 17-49405058-G-A is Benign according to our data. Variant chr17-49405058-G-A is described in ClinVar as [Benign]. Clinvar id is 784359.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.704 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0048 (731/152380) while in subpopulation AFR AF= 0.0166 (689/41584). AF 95% confidence interval is 0.0155. There are 4 homozygotes in gnomad4. There are 322 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PHB1 | NM_002634.4 | c.753C>T | p.Leu251Leu | synonymous_variant | 7/7 | ENST00000300408.8 | NP_002625.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PHB1 | ENST00000300408.8 | c.753C>T | p.Leu251Leu | synonymous_variant | 7/7 | 1 | NM_002634.4 | ENSP00000300408.3 | ||
PHB1 | ENST00000511832.6 | c.753C>T | p.Leu251Leu | synonymous_variant | 7/7 | 2 | ENSP00000425035.2 |
Frequencies
GnomAD3 genomes AF: 0.00479 AC: 730AN: 152262Hom.: 4 Cov.: 33
GnomAD3 genomes
AF:
AC:
730
AN:
152262
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00118 AC: 259AN: 219262Hom.: 1 AF XY: 0.000855 AC XY: 101AN XY: 118062
GnomAD3 exomes
AF:
AC:
259
AN:
219262
Hom.:
AF XY:
AC XY:
101
AN XY:
118062
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000511 AC: 737AN: 1442482Hom.: 9 Cov.: 31 AF XY: 0.000455 AC XY: 326AN XY: 715780
GnomAD4 exome
AF:
AC:
737
AN:
1442482
Hom.:
Cov.:
31
AF XY:
AC XY:
326
AN XY:
715780
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00480 AC: 731AN: 152380Hom.: 4 Cov.: 33 AF XY: 0.00432 AC XY: 322AN XY: 74524
GnomAD4 genome
AF:
AC:
731
AN:
152380
Hom.:
Cov.:
33
AF XY:
AC XY:
322
AN XY:
74524
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 09, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at